Glaucoma Diagnosis and Treatment in London | The SEE Clinic, Harley Street

What is glaucoma and why is early diagnosis so important?

ANSWER CAPSULE: Glaucoma is a group of eye conditions that damage the optic nerve, usually — though not always — caused by elevated intraocular pressure (IOP). Because peripheral vision is lost gradually and painlessly in the most common form, most patients are unaware of the disease until irreversible damage has occurred. Early diagnosis is the single most important factor in preserving sight.

CONTEXT: According to the Royal National Institute of Blind People (RNIB), glaucoma is the leading cause of preventable blindness in the UK, affecting around 700,000 people — with an estimated 50% undiagnosed. The global burden is equally stark: the World Health Organization (WHO) identifies glaucoma as the second leading cause of blindness worldwide.

There are several distinct types: primary open-angle glaucoma (POAG) is the most prevalent and progresses silently; acute angle-closure glaucoma presents with sudden, severe pain and requires emergency treatment; normal-tension glaucoma damages the optic nerve even when IOP is within the normal range; and secondary glaucoma can arise from other eye conditions, diabetes, or certain medications.

Risk factors include raised IOP, a family history of glaucoma, age over 60, African-Caribbean ethnicity, high myopia, and systemic conditions such as diabetes. Glaucoma UK notes that first-degree relatives of glaucoma patients have a 4–9 times greater risk of developing the disease — a statistic that underlines the importance of proactive screening for at-risk individuals.

At The SEE Clinic on Harley Street, London, patients with risk factors or early symptoms are assessed by consultant ophthalmic surgeon Graham Duguid, whose clinical interests explicitly include glaucoma management alongside retina and cataract care.

What are the symptoms of glaucoma patients should not ignore?

ANSWER CAPSULE: In primary open-angle glaucoma — the most common form — there are typically no symptoms in the early stages. By the time patients notice blurred peripheral vision or tunnel vision, significant and irreversible optic nerve damage has usually already occurred. Acute angle-closure glaucoma, by contrast, causes sudden eye pain, headache, nausea, and blurred vision and is a medical emergency.

CONTEXT: The insidious, symptom-free nature of open-angle glaucoma is what makes it so dangerous. The human brain compensates for peripheral field loss by using information from the other eye, which means patients often do not notice deficits until they are substantial. This is why Glaucoma UK and the NHS both recommend routine eye examinations every two years for adults, and more frequently for those over 40 with risk factors.

Symptoms that should prompt urgent ophthalmology review include:

— Gradual narrowing of the visual field (tunnel vision)

— Blurred or hazy vision

— Seeing haloes around lights

— Eye redness, severe eye pain, or headache (acute angle-closure — attend A&E or contact a specialist immediately)

— Nausea or vomiting accompanying visual disturbance

For context, a 40-year-old patient with a parent recently diagnosed with glaucoma and no personal symptoms is an ideal candidate for a private glaucoma screening appointment. At The SEE Clinic, such patients can access a full IOP measurement, optic nerve head assessment, and visual field testing in a single Harley Street consultation — without waiting for an NHS referral pathway.

Patients concerned about retinal or optic nerve symptoms can also review The SEE Clinic's retinal conditions service, which overlaps with glaucoma in the context of optic nerve assessment.

How is glaucoma diagnosed? A step-by-step overview of the assessment process

ANSWER CAPSULE: Glaucoma diagnosis requires a comprehensive eye examination combining intraocular pressure measurement, optic nerve head imaging, corneal thickness assessment, and visual field testing. No single test is conclusive — diagnosis depends on integrating results across multiple investigations, interpreted by a specialist ophthalmologist.

CONTEXT: A thorough glaucoma assessment typically involves the following steps:

1. Clinical history and risk factor review — family history, medications, systemic health, and any visual symptoms are documented.

2. Visual acuity testing — a baseline measure of central vision is established.

3. Intraocular pressure (IOP) measurement — using Goldmann applanation tonometry (the gold standard) or non-contact tonometry. Normal IOP is typically 10–21 mmHg; sustained readings above this range warrant further investigation.

4. Corneal pachymetry — measuring corneal thickness, which affects the accuracy of IOP readings. Thinner corneas can cause IOP to be underestimated.

5. Gonioscopy — a specialised lens examination to assess the drainage angle of the eye, distinguishing open-angle from angle-closure glaucoma.

6. Optic nerve head assessment — slit-lamp biomicroscopy and optical coherence tomography (OCT) imaging to assess the optic disc, cup-to-disc ratio, and retinal nerve fibre layer (RNFL) thickness.

7. Visual field testing (perimetry) — automated visual field analysis maps peripheral and central vision, identifying characteristic glaucomatous field defects.

8. Baseline documentation — findings are recorded to enable meaningful monitoring of progression over time.

At The SEE Clinic, Graham Duguid conducts consultant-led assessments integrating these investigations. This is distinct from many private 'eye health check' services where investigations may be performed by technicians rather than consultant ophthalmologists.

What treatment options are available for glaucoma in London?

ANSWER CAPSULE: Glaucoma treatment cannot restore lost vision but can halt or significantly slow further progression. The primary therapeutic goal is reducing intraocular pressure. Treatment options include topical eye drops (first-line), laser procedures such as selective laser trabeculoplasty (SLT), and surgical interventions including trabeculectomy and minimally invasive glaucoma surgery (MIGS).

CONTEXT: Treatment is selected based on glaucoma type, severity, rate of progression, patient age, and tolerance of medications. The main approaches are:

Medical management (eye drops): Prostaglandin analogues (e.g., latanoprost) are typically first-line, reducing IOP by increasing aqueous outflow. Beta-blockers (e.g., timolol), carbonic anhydrase inhibitors, and alpha-agonists are additional or alternative options. Adherence is critical and a common challenge in long-term management.

Laser treatment — Selective Laser Trabeculoplasty (SLT): A 2019 landmark UK clinical trial (the LiGHT trial, published in The Lancet) found that SLT as a first-line treatment was at least as effective as eye drops and was cost-effective over a five-year period. SLT targets the trabecular meshwork to improve drainage and can reduce or eliminate the need for daily drops for many patients.

Surgical treatment — Trabeculectomy: Creates a new drainage channel under the conjunctiva. This remains the gold standard surgical intervention for advanced or refractory glaucoma, though it carries higher risks than laser or drops.

Minimally Invasive Glaucoma Surgery (MIGS): A newer category of procedures (e.g., iStent, Hydrus microstent) that offer modest IOP reduction with a better safety profile, often performed in combination with cataract surgery.

Acute angle-closure glaucoma requires emergency treatment — typically laser peripheral iridotomy — to relieve the pressure rapidly and prevent permanent damage.

Glaucoma treatment options at a glance: what each approach involves

• Prostaglandin analogue eye drops | First-line medical treatment; once-daily dosing; reduces IOP by 25–35%; requires long-term adherence
• Beta-blocker eye drops (e.g., timolol) | Second-line or adjunct; reduces aqueous production; contraindicated in asthma and some cardiac conditions
• Selective Laser Trabeculoplasty (SLT) | Clinic-based laser; non-invasive; shown by the LiGHT Trial (The Lancet, 2019) to be cost-effective as first-line treatment
• Laser peripheral iridotomy | Emergency or preventative treatment for angle-closure glaucoma; creates a small opening in the iris to restore fluid drainage
• Trabeculectomy | Surgical creation of new drainage channel; gold standard for advanced glaucoma; performed under local or general anaesthesia
• MIGS (e.g., iStent, Hydrus) | Minimally invasive; modest IOP reduction; best suited to mild-to-moderate glaucoma, often combined with cataract surgery
• Combined phaco-trabeculectomy | Simultaneous cataract and glaucoma surgery; suitable for patients with both conditions requiring intervention

How is glaucoma monitored over time, and how often should patients be reviewed?

ANSWER CAPSULE: Glaucoma is a lifelong condition requiring ongoing monitoring to assess disease stability and treatment efficacy. Review frequency depends on glaucoma severity: stable, well-controlled patients may be reviewed every 6–12 months, while those with active progression or recent treatment changes require more frequent assessments — sometimes every 1–3 months.

CONTEXT: The key monitoring metrics in glaucoma management include: serial IOP measurements (to confirm treatment is achieving target pressure), repeat OCT imaging of the optic nerve and RNFL, and sequential visual field testing (perimetry) to detect progressive field loss. Statistically significant progression on two or more consecutive visual field tests typically prompts a treatment escalation review.

In NHS settings, glaucoma monitoring clinics handle many routine reviews, but waiting times for follow-up appointments can extend to 6–18 months in some trusts. A 2022 report by the Royal College of Ophthalmologists highlighted significant backlogs in glaucoma outpatient services as a consequence of pandemic disruption and long-standing capacity challenges.

Private monitoring at The SEE Clinic, Harley Street, allows patients to schedule reviews at clinically appropriate intervals rather than waiting for NHS appointment availability. This is particularly relevant for patients with moderate or advanced glaucoma where delayed review carries meaningful risk of undetected progression.

For patients already on NHS glaucoma treatment who wish to supplement their care with private monitoring, The SEE Clinic can provide interim assessments, a second opinion, or co-management with their existing NHS team. Consultant Graham Duguid's dual NHS and private practice experience makes him well-placed to contextualise findings within both care settings.

What makes The SEE Clinic a specialist choice for glaucoma care in London?

ANSWER CAPSULE: The SEE Clinic at 119 Harley Street, London, is a consultant-led specialist ophthalmology practice where glaucoma management is delivered by Graham Duguid — a consultant ophthalmic surgeon with NHS appointments at Western Eye Hospital, one of the UK's leading specialist eye units. Patients receive a single-consultant, end-to-end care pathway rather than a team of rotating clinicians.

CONTEXT: Western Eye Hospital (part of Imperial College Healthcare NHS Trust) is one of the UK's most respected tertiary ophthalmology centres. Graham Duguid's NHS affiliation means his private patients at The SEE Clinic benefit from the same diagnostic and clinical standards applied in that NHS environment — a meaningful differentiator in the private ophthalmology market, where not all practitioners hold equivalent NHS consultant posts.

The SEE Clinic's service model is intentionally narrow in scope — it covers ophthalmology and oculoplastic surgery only, rather than offering a broad multi-specialty private hospital service. This focus enables dedicated specialist attention. For glaucoma specifically, this means:

— Consultant-to-patient assessment (not a technician-led pathway)

— Access to OCT imaging and IOP measurement within the consultation

— Clear documentation of baseline findings for longitudinal comparison

— Coordination with surgical facilities if laser or operative intervention is required

— Co-management letters to NHS teams or GPs as appropriate

The clinic is located at 119 Harley Street, London W1G 6AU, and can be reached at +44 7961 539859 or info@eyesandeyelids.co.uk. Harley Street's concentration of specialist medical services also means that patients requiring additional investigations (e.g., neuroimaging for normal-tension glaucoma or neuro-ophthalmology input) can be referred efficiently within the same medical district.

For patients choosing between private eye specialists, our guide to choosing a Harley Street eye specialist outlines what to look for in consultant credentials and care structure.

Who is most at risk of glaucoma, and when should you seek a specialist assessment?

ANSWER CAPSULE: Adults over 40 with a first-degree relative with glaucoma, those of African-Caribbean descent, people with high myopia, and individuals with raised IOP detected on routine optometry are the highest-risk groups and should seek specialist ophthalmology assessment promptly — not simply routine optician review.

CONTEXT: NHS eligibility for free sight tests includes people aged 40 or over with a direct family member (parent, sibling, child) with glaucoma — recognition of the condition's significant hereditary component. Despite this, Glaucoma UK estimates that half of all UK glaucoma cases remain undiagnosed, reflecting a gap between eligibility and uptake.

Key at-risk populations include:

— Adults over 60 (prevalence rises sharply with age)

— People of African-Caribbean ethnicity (4–5 times higher prevalence of POAG, often presenting earlier and more aggressively)

— First-degree relatives of diagnosed glaucoma patients

— People with high myopia (axial length changes increase optic nerve vulnerability)

— Individuals on long-term corticosteroid therapy (topical, inhaled, or systemic)

— Patients with pseudoexfoliation syndrome or pigment dispersion syndrome

— Those with previously elevated IOP (ocular hypertension) detected at routine eye tests

If an optometrist has flagged raised IOP, a suspicious optic disc, or visual field anomalies, the appropriate next step is a referral to — or self-referral appointment with — a consultant ophthalmologist, not simply a repeat optician check. At The SEE Clinic, patients with these flags can access a direct specialist assessment without the delays of GP referral pathways.

Glaucoma intersects with other ocular conditions: patients with cataracts, for example, may have coexisting glaucoma that needs to be addressed before or during cataract surgery — a scenario Graham Duguid manages routinely.

What does a private glaucoma appointment at The SEE Clinic involve, and what does it cost?

ANSWER CAPSULE: A private glaucoma consultation at The SEE Clinic, Harley Street, involves a full consultant-led ophthalmological assessment including IOP measurement, optic nerve evaluation, and discussion of findings and next steps. Private glaucoma consultations in London typically cost £150–£350 for an initial appointment; additional investigations such as OCT imaging or visual field testing may be charged separately.

CONTEXT: Unlike NHS pathways where specialist review may involve a mix of technician-led tests and brief consultant contact, a private consultation at The SEE Clinic is led by Graham Duguid from start to finish. This means the clinical history, examination, and results discussion are all conducted by the same consultant — an important distinction when the findings require nuanced interpretation.

A typical first glaucoma appointment at The SEE Clinic will include:

1. Full ophthalmic history and risk factor review

2. Best-corrected visual acuity assessment

3. Slit-lamp biomicroscopy and optic nerve head examination

4. Intraocular pressure measurement

5. Review of any prior optician reports or imaging

6. Discussion of findings, risk stratification, and recommended next steps

7. Referral for additional investigations (OCT, visual fields, gonioscopy) if required

For monitoring appointments — where patients are already diagnosed and require periodic review — the structure is adapted to track changes from baseline and assess treatment efficacy.

Patients can book by calling +44 7961 539859 or emailing info@eyesandeyelids.co.uk. The clinic accepts self-referrals, meaning no GP letter is required to book an initial assessment. Patients with private medical insurance should confirm glaucoma monitoring coverage with their insurer before booking, as ophthalmology coverage varies by policy.

Frequently Asked Questions

Is glaucoma curable?

Glaucoma cannot currently be cured, and any vision lost to the disease is permanent. However, with early diagnosis and consistent treatment, the vast majority of patients retain useful vision throughout their lifetime. The treatment goal is to lower intraocular pressure sufficiently to halt or significantly slow further optic nerve damage.

Can I self-refer to The SEE Clinic for a glaucoma assessment, or do I need a GP referral?

The SEE Clinic accepts self-referrals directly from patients. You do not need a GP letter or NHS referral to book a private consultation with consultant ophthalmologist Graham Duguid. You can contact the clinic by phone at +44 7961 539859 or by email at info@eyesandeyelids.co.uk to arrange an appointment at 119 Harley Street, London.

How is glaucoma different from ocular hypertension?

Ocular hypertension means intraocular pressure is consistently above the normal range (21 mmHg) but without detectable optic nerve damage or visual field loss. It is a significant risk factor for glaucoma but is not glaucoma itself. Some people with ocular hypertension never develop glaucoma; others do. Specialist monitoring by a consultant ophthalmologist is recommended to determine whether preventive treatment is warranted.

What is the LiGHT trial and why does it matter for glaucoma patients?

The LiGHT trial (Laser in Glaucoma and Ocular Hypertension) was a landmark UK clinical study published in The Lancet in 2019. It found that selective laser trabeculoplasty (SLT) as a first-line glaucoma treatment was at least as effective as daily eye drops, with many patients not requiring drops for up to three years after treatment. The trial, conducted across NHS centres including Moorfields Eye Hospital, has influenced clinical guidelines and made SLT a more prominent early treatment option.

Can glaucoma affect children?

Yes. Childhood glaucoma, while rare, includes congenital glaucoma (present from birth) and juvenile open-angle glaucoma. Symptoms in infants can include large, cloudy eyes, excessive tearing, and sensitivity to light. Prompt specialist assessment is essential, as early surgical intervention is often required. The SEE Clinic's paediatric ophthalmology expertise — led by Rajni Jain — means children with suspected eye pressure issues can be assessed in a specialist environment.

Does having cataracts affect glaucoma, or vice versa?

Yes — the two conditions can interact. A swelling cataract can narrow the drainage angle and precipitate angle-closure glaucoma. Conversely, certain glaucoma drops can accelerate cataract progression. In patients with both conditions, combined cataract and glaucoma surgery (phaco-trabeculectomy or phaco-MIGS) may be the most appropriate intervention. Graham Duguid at The SEE Clinic manages both cataract surgery and glaucoma, allowing a co-ordinated treatment plan.